| |
|
|
|
Capricor Therapeutics- Inc.  
|
|
1.41 0.03 (0.02%) |
06-22 16:00 |
|
Open: |
1.35 |
Pre close: |
1.38 |
Target:
|
1.69
|
|
High: |
1.41 |
Low: |
1.35 |
Resistance:
|
1.45
1.57
|
|
Volume: |
130,523 |
Market Cap: |
41M |
Support:
|
1.25
1.04
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.40
 |
MACD |
MACD(12,26):
|
0.01  |
|
MA(20): |
1.35 |
Signal(12,26,9): |
0.01 |
|
MA(100): |
1.52 |
Stochastic Oscillator |
%K(14,3):
|
48.96 |
|
MA(250): |
1.60 |
%D(3): |
48.26 |
|
Average Volume(K) |
3-Month: |
22026
|
52-Week |
High:
|
4.25 |
|
10-Days: |
41228 |
Low: |
0.66 |
|
RSI |
RSI(14):
|
55.01 |
Change(%): |
107.4 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.530 |
Return on Equity (ttm) |
219.4 |
Shares Out. (M) |
29.11 |
|
EPS Est. Current Year |
-0.700 |
Return on Assets (ttm) |
15.3 |
Shares Float (M) |
25.43 |
|
EPS Est. Next Year |
-0.760 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.190 |
Qtrly Rev. Growth |
-54.6 |
% Held by Institutions |
3.10 |
|
Forward EPS |
-0.430 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
1368 |
|
Book Value (p.s.) |
3.790 |
EBITDA (p.s.) |
-0.203 |
P/E |
-2.66 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.37 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-12.97 |
P/S |
456056640.00 |
|
Operating Margin |
-594.03 |
Levered Free Cash Flow
(M) |
-8.23 |
P/CF |
-3.16 |
|
|
|
|
|
|
